Our longitudinal follow-up of AOSD patients showed that the expression levels of TLR7 MyD88-dependent signaling molecules, including TLR7, MyD88, IRAK4, TRAF6, and IFN-α, decreased significantly, paralleling the clinical remission and a decrease in inflammatory parameters after therapy (Figure 4). Here, TLR7 is linked to adult-onset Still disease.